✦ LIBER ✦

Rituximab Induces Effective Clearance of Minimal Residual Disease in Molecular Relapses of Mantle Cell Lymphoma

✍ Scribed by Marco Ladetto; Michele Magni; Gloria Pagliano; Federica De Marco; Daniela Drandi; Irene Ricca; Monica Astolfi; Paola Matteucci; Anna Guidetti; Barbara Mantoan; Chiara Lobetti Bodoni; Manuela Zanni; Mario Boccadoro; Alessandro M. Gianni; Corrado Tarella

Book ID: 116279068
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 238 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.07.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab-based pre-emptive treatment of

Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma

✍ Simone Ferrero, Luigia Monitillo, Barbara Mantoan, Daniela Barbero… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 852 KB

Cost-Effectiveness Of Bendamustine+Ritux

Cost-Effectiveness Of Bendamustine+Rituximab Versus Fludarabine+Rituximab In The Treatment Of Relapsed Indolent Non-Hodgkin's And Mantle Cell Lymphomas In Canada

✍ Lachaine, J.; Beauchemin, C.; Mathurin, K.; Aissa, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Quantitative monitoring of cyclin D1 exp

Quantitative monitoring of cyclin D1 expression: A molecular marker for minimal residual disease monitoring and a predictor of the disease outcome in patients with mantle cell lymphoma

✍ Helena Brizova; Marketa Kalinova; Lenka Krskova; Marcela Mrhalova; Roman Kodet 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 235 KB

## Abstract In mantle cell lymphoma (MCL), minimal residual disease (MRD) is an indicator of the disease outcome. Quantitative methods used so far do not provide a suitable molecular marker in 30–70% patients with MCL (depending on the technique used). We tested cyclin D1 as a marker for quantitati

*701 Detection of Minimal Residual Disea

*701 Detection of Minimal Residual Disease Following Induction Immunochemotherapy Predicts Progression Free Survival in Mantle Cell Lymphoma: Final Results of CALGB 59909

✍ Hongtao Liu; Jeffrey Johnson; Greg Koval; Greg Malnassy; Pamela Ihonor; Dorie Sh 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 143 KB

Hepatosplenic gamma-delta T-cell maligna

Hepatosplenic gamma-delta T-cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow-up

✍ F. GARCIA-SANCHEZ; J. MENÁRGUEZ; E. CRISTOBAL; A. CANTAI.EJO; J. GIL; P. ALGARA; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB